Table 1.
Correlations between CCT7 and clinicopathological features in patients with endometrial cancer.
| Characteristic | Cases | CCT7 | CCT7 | P-value |
|---|---|---|---|---|
| +(%) | –(%) | |||
| Age(years) | ||||
| <60 | 15 | 9 (60.0) | 6 (40.0) | 0.194 |
| ≥60 | 72 | 30 (41.7) | 42 (58.3) | |
| Menopause | ||||
| Yes | 42 | 23 (54.8) | 19 (45.2) | 0.072 |
| No | 45 | 16 (35.6) | 29 (64.4) | |
| Tissue type | ||||
| Carcinous | 87 | 39 (50.7) | 38 (49.3) | 0.033* |
| Pericarcinous | 72 | 24 (33.3) | 48 (66.7) | |
| Pathological stage | ||||
| I–II | 73 | 29 (39.7) | 44 (60.3) | 0.029* |
| III–IV | 14 | 10 (71.4) | 4 (28.6) | |
| Histological grade | ||||
| G1 | 49 | 19 (38.8) | 30 (61.2) | 0.182 |
| G2 | 33 | 16 (48.5) | 17 (51.5) | |
| G3 | 5 | 4 (80.0) | 1 (20.0) | |
| Depth of invasion | ||||
| <1/2 | 67 | 26 (38.8) | 41 (61.2) | 0.039* |
| ≥1/2 | 20 | 13 (65.0) | 7 (35.0) | |
| Pathological type | ||||
| Endometrioid adenocarcinoma | 75 | 34 (45.3) | 41 (54.7) | 0.813 |
| Other Types§ | 12 | 5 (41.7) | 7 (58.3) | |
| Preoperative chemotherapy | ||||
| Yes | 31 | 16 (51.6) | 15 (48.4) | 0.344 |
| No | 56 | 23 (41.1) | 33 (58.9) | |
CCT7+: >6 points, strongly positive; CCT7–: ≤6 points, negative and positive;
§
other types included (cases/CCT7+/CCT7–): Adenosquamous carcinoma (5/1/4), Serous papillary adenocarcinoma (3/1/2), Clear cell carcinoma (2/1/1), and Mucinous carcinoma (2/2/0); Statistical analyses were performed using Chi-square tests.
*
P < 0.05 was considered statistically significant.